Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera - Nature Medicine

We previously reported that BNT162b2, a nucleoside-modified RNA vaccine that encodes the SARS-CoV-2 full-length, prefusion-stabilized spike glycoprotein, elicited dose-dependent SARS-CoV-2-neutralizing GMTs that were similar to or higher than the GMT of a panel of SARS-CoV-2 convalescent human serum samples1. We subsequently reported that, in a randomized, placebo-controlled trial of approximately

[asanoshiro200014]

ファイザーのワクチンは変異株にも効くという趣旨の論文。気になるのは、実験に使った変異株は代表的な変異が入っているだけで、全ての変異を持つものではないこと。